All In MedTech

FDA Clearance Tracker · P040021-S061

Epic Elite Mitral; Epic Elite Aortic; Epic Supra G3 valves

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P040021-S061
Device name
Epic Elite Mitral; Epic Elite Aortic; Epic Supra G3 valves
Applicant location
St. Paul, MN
Received
Dec 22, 2025
Decided
Jun 22, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P040021

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

Approval for a next generation of the Epic family of tissue heart valves, collectively referred to as Epic Elite/G3. The changes to the Epic Elite/G3 valves include the addition of an expansion feature on the stent to facilitate future Valve-in-Valve (ViV) procedures, a change in stent material to an equivalent material from the same supplier, and minor marking and suture changes.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.